ProShare Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,885
Closed -$211K 2242
2021
Q2
$211K Sell
3,885
-96
-2% -$5.27K ﹤0.01% 2115
2021
Q1
$223K Buy
+3,981
New +$199K ﹤0.01% 1975
2014
Q2
Sell
-14,207
Closed -$321K 2600
2014
Q1
$321K Buy
+14,207
New +$347K ﹤0.01% 2197
2013
Q4
Sell
-9,468
Closed -$225K 1803
2013
Q3
$225K Buy
+9,468
New +$203K 0.01% 2110

Other funds holding SRDX

ProShare Advisors's SRDX Position: Q3 2021 in Review

ProShare Advisors sold out of Surmodics (SRDX) in Q3 2021, closing a stake of 3,885 shares — an estimated $211K sold.

ProShare Advisors first reported a position in SRDX in Q3 2013 and held it in 4 quarters. The position peaked at $321K in Q1 2014. 152 funds tracked by Wall St. Rank hold SRDX as of Q3 2021.

  • ProShare Advisors reported no remaining Surmodics position as of Q3 2021 after selling out during the quarter.
  • ProShare Advisors sold 3,885 Surmodics shares in Q3 2021, an estimated $211K.
  • ProShare Advisors first reported a position in Surmodics in Q3 2013 and held it in 4 quarters.
  • ProShare Advisors's Surmodics position peaked at $321K in Q1 2014.
  • 152 funds tracked by Wall St. Rank held Surmodics as of Q3 2021.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.